Literature DB >> 22173216

Toxicity profiles of subretinal indocyanine green, Brilliant Blue G, and triamcinolone acetonide: a comparative study.

Rasmus Ejstrup1, M la Cour, S Heegaard, J F Kiilgaard.   

Abstract

BACKGROUND: This study introduces a novel porcine model to examine the histopathological and electrophysiological consequences of retinotoxicity exerted by dyes commonly used for internal limiting membrane (ILM) staining.
METHODS: Indocyanine green (ICG) 0.5 mg/ml, Brilliant Blue G (BBG) 0.25 mg/ml and triamcinolone acetonide (TA) 13 mg/ml was injected subretinally in 12 vitrectomized pig eyes. At 6 weeks, retinas were examined by multifocal electroretinography (mfERG), ophthalmoscopy, fluorescein angiograpy, histopathology, and apoptosis assay.
RESULTS: mfERG responses were significantly lower in ICG-injected eyes than in healthy fellow eyes (p = 0.039). The ratio between injected eyes and healthy fellow eyes was lower in the ICG group than in the BBG (p = 0.009) and TA group (p = 0.025). No difference between BBG and TA existed. All retinas were reattached, and fluorescein angiographies showed a window defect corresponding to the injected areas but no blood-retina barrier break-down. Histopathology confirmed damage to the outer retina after ICG, but not after BBG and TA. No apoptosis was found at 6 weeks.
CONCLUSIONS: Subretinal ICG induces histological and functional damage to the retina, suggesting that ICG should be used with caution in macular hole surgery, where subretinal migration can occur. In contrast, BBG and TA appear safe after subretinal injection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22173216     DOI: 10.1007/s00417-011-1886-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  56 in total

1.  Retinal toxicity of indocyanine green in albino rabbits.

Authors:  Michaella Goldstein; Esther Zemel; Anat Loewenstein; Ido Perlman
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-05       Impact factor: 4.799

2.  Reduced incidence of intraoperative complications in a multicenter controlled clinical trial of triamcinolone in vitrectomy.

Authors:  Keita Yamakiri; Taiji Sakamoto; Yoshihiro Noda; Masaaki Nakahara; Nobuchika Ogino; Toshiaki Kubota; Mitsunobu Yokoyama; Mariko Furukawa; Yasushi Sonoda; Tomomi Yamada; Norihito Doi; Hiroshi Enaida; Yasuaki Hata; Tatsuro Ishibashi
Journal:  Ophthalmology       Date:  2007-02       Impact factor: 12.079

3.  Triamcinolone-assisted internal limiting membrane peeling.

Authors:  Gaurav K Shah; Brett J Rosenblatt; Kevin J Blinder; M Gilbert Grand; Morton Smith
Journal:  Retina       Date:  2005-12       Impact factor: 4.256

4.  Safety testing of indocyanine green in an ex vivo porcine retina model.

Authors:  Parykshit Saikia; Tim Maisch; Karin Kobuch; Timothy L Jackson; Wolfgang Bäumler; Rolf-Markus Szeimies; Veit-Peter Gabel; Jost Hillenkamp
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-11       Impact factor: 4.799

5.  Functional assessment of the possible toxicity of indocyanine green dye in macular hole surgery.

Authors:  Mária Ferencz; Gábor Márk Somfai; Agnes Farkas; Illés Kovács; Balázs Lesch; Zsuzsa Récsán; János Nemes; György Salacz
Journal:  Am J Ophthalmol       Date:  2006-11       Impact factor: 5.258

6.  Pharmacokinetics of intravitreal glial cell line-derived neurotrophic factor: experimental studies in pigs.

Authors:  R Ejstrup; J F Kiilgaard; B A Tucker; H J Klassen; M J Young; M La Cour
Journal:  Exp Eye Res       Date:  2010-09-29       Impact factor: 3.467

7.  Morphologic and clinical study of the retinal circulation in the miniature pig. A: Morphology of the retinal microvasculature.

Authors:  P Simoens; L De Schaepdrijver; H Lauwers
Journal:  Exp Eye Res       Date:  1992-06       Impact factor: 3.467

8.  Persistent subretinal indocyanine green induces retinal pigment epithelium atrophy.

Authors:  Akira Hirata; Yasuya Inomata; Takahiro Kawaji; Hidenobu Tanihara
Journal:  Am J Ophthalmol       Date:  2003-08       Impact factor: 5.258

9.  An in vivo evaluation of Brilliant Blue G in animals and humans.

Authors:  M Remy; S Thaler; R G Schumann; C A May; M Fiedorowicz; F Schuettauf; M Grüterich; S G Priglinger; M M Nentwich; A Kampik; C Haritoglou
Journal:  Br J Ophthalmol       Date:  2008-08       Impact factor: 4.638

10.  Surgical removal of idiopathic epiretinal membrane with or without the assistance of indocyanine green: a randomised controlled clinical trial.

Authors:  Jost Hillenkamp; Parykshit Saikia; Wolfgang A Herrmann; Carsten Framme; Veit-Peter Gabel; Helmut G Sachs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12-21       Impact factor: 3.535

View more
  14 in total

1.  Macular peeling-induced retinal damage: clinical and histopathological evaluation after using different dyes.

Authors:  Mario R Romano; Gennaro Ilardi; Mariantonia Ferrara; Gilda Cennamo; Barbara Parolini; Cesare Mariotti; Stefania Staibano; Giovanni Cennamo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-08       Impact factor: 3.117

2.  Internal limiting membrane peeling with different dyes in the surgery of idiopathic macular hole: a systematic review of literature and network Meta-analysis.

Authors:  Shan-Shan Li; Ran You; Min Li; Xiao-Xiao Guo; Lu Zhao; Yan-Ling Wang; Xi Chen
Journal:  Int J Ophthalmol       Date:  2019-12-18       Impact factor: 1.779

3.  LONG-TERM RETROSPECTIVE ANALYSIS OF VISUAL ACUITY AND OPTICAL COHERENCE TOPOGRAPHIC CHANGES AFTER SINGLE VERSUS DOUBLE PEELING DURING VITRECTOMY FOR MACULAR EPIRETINAL MEMBRANES.

Authors:  Jesse J Jung; Quan V Hoang; Megan L Ridley-Lane; Dov B Sebrow; Elona Dhrami-Gavazi; Stanley Chang
Journal:  Retina       Date:  2016-11       Impact factor: 4.256

Review 4.  Early and late inner retinal changes after inner limiting membrane peeling.

Authors:  Francesco Pichi; Andrea Lembo; Mariachiara Morara; Chiara Veronese; Micol Alkabes; Paolo Nucci; Antonio P Ciardella
Journal:  Int Ophthalmol       Date:  2013-07-18       Impact factor: 2.031

5.  Inner retinal thinning after Brilliant Blue G-assisted internal limiting membrane peeling for vitreoretinal interface disorders.

Authors:  Vikas Ambiya; Abhilash Goud; Mitali Khodani; Jay Chhablani
Journal:  Int Ophthalmol       Date:  2016-06-14       Impact factor: 2.031

6.  Long-term outcomes of 3 surgical adjuvants used for internal limiting membrane peeling in idiopathic macular hole surgery.

Authors:  Noriko Mochizuki; Teiko Yamamoto; Hiroshi Enaida; Tatsuro Ishibashi; Hidetoshi Yamashita
Journal:  Jpn J Ophthalmol       Date:  2014-09-09       Impact factor: 2.447

7.  Development and preclinical evaluation of a new viewing filter system to control reflection and enhance dye staining during vitrectomy.

Authors:  Hiroshi Enaida; Yoshiyuki Hachisuka; Yukiyasu Yoshinaga; Yasuhiro Ikeda; Toshio Hisatomi; Shigeo Yoshida; Yusuke Oshima; Kazuaki Kadonosono; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-09       Impact factor: 3.117

8.  Evaluation of macular retinal ganglion cell-inner plexiform layer thickness after vitrectomy with internal limiting membrane peeling for idiopathic macular holes.

Authors:  Alfonso L Sabater; Álvaro Velázquez-Villoria; Miguel A Zapata; Marta S Figueroa; Marta Suárez-Leoz; Luis Arrevola; María-Ángeles Teijeiro; Alfredo García-Layana
Journal:  Biomed Res Int       Date:  2014-07-07       Impact factor: 3.411

9.  Treatment of Myopic Foveoschisis with Air Versus Perfluoropropane: A Retrospective Study.

Authors:  Jing Jiang; Xiaoyu Yu; Fanglin He; Linna Lu; Yiwen Qian; Zhenzhen Zhang; Dongqing Zhu; Xiaofang Xu; Zhiliang Wang
Journal:  Med Sci Monit       Date:  2017-07-10

10.  Repeated subretinal surgery and removal of subretinal decalin is well tolerated - evidence from a porcine model.

Authors:  Nina Buus Sørensen; Kristian Klemp; Troels Wesenberg Kjær; Steffen Heegaard; Morten la Cour; Jens Folke Kiilgaard
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-06-12       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.